IntroductionPsoriatic arthritis (PsA) – a spondyloarthropathy – is a heterogeneous and potentially severe rheumatic disease. While PsA can occur at any age, its usual age of onset is between the ages of 35 and 45 ; more than 20 % of psoriasis patients in Germany are thought to be affected . Overall, 0.1–1 % of the population have some form of PsA . In approximately 70 % of cases, joint involvement is preceded by cutaneous manifestations. However, the latter may also develop simultaneously (approximately 15 %), at a later point in time (approximately 10 %), or not at all (5 %) .Clinically, PsA is characterized by rheumatoid factor‐negative oligo‐ or polyarthritis, enthesitis (inflammation of tendon insertions), dactylitis (inflammation of an entire toe or finger), and/or spondylitis. Roughly 3–5 % of PsA patients develop mutilating arthritis, a destructive disease variant .Correct and early diagnosis paramount as regards the progression of PsA; however, given the heterogeneous nature of the disease, establishing the diagnosis poses a challenge to the various medical specialties involved . The interval between initial disease manifestations and confirmation of the diagnosis is, on average, five years . Evidence of an active inflammatory musculoskeletal disease is a crucial step in diagnosing PsA. Since 2006, the Classification
Journal Der Deutschen Dermatologischen Gesellschaft – Wiley
Published: Jan 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera